Our projects

Over the last decade, the treatment of immunological diseases has improved dramatically. However, current drugs have several shortcomings, such as adverse side effects, administration forms that often require visits to the hospital and poor response or resistance in some patients. Cyxone is addressing the need for efficacious, tolerable and convenient drugs against autoimmune disease that can modify or prevent disease progression at an early stage.